Hoʻohui ʻia nā mea maʻi hanu

ʻO ka wehewehe pōkole:

Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka maʻi maʻi influenza A, ka maʻi influenza B, ka maʻi hanu syncytial, adenovirus, ka rhinovirus kanaka a me ka mycoplasma pneumoniae nucleic acids i loko o nā swabs nasopharyngeal kanaka a me nā mea hoʻohālike oropharyngeal swab. Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen respiratory, a hāʻawi i ke kumu diagnostic molecular auxiliary no ka ʻike a me ka mālama ʻana i nā maʻi pathogen respiratory.

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Wikiō pili

Manaʻo manaʻo (2)

ʻO ka nui o nā ʻike hoʻokele papahana a hoʻokahi wale nō i hoʻokahi kumu hoʻohālike e hana i ke koʻikoʻi nui o ka kamaʻilio hui a me kā mākou ʻike maʻalahi i kāu mau manaʻo noHbv Dna Pcr Hoao, ʻO ka Hormone Hoʻoikaika Follicle, Kolera ʻAoʻona ʻIke, Welina mai e hele iā mākou i kēlā me kēia manawa no ka ʻoihana hui i hōʻoia ʻia.

Mea Hoʻohui Hoʻohui ʻia ʻo Respiratory Pathogens:

inoa huahana

HWTS-RT050-ʻEono ʻano o ka pahu hoʻomaʻamaʻa ʻana i ka ʻakika Nucleic Acid Detection Kit(Fluorescence PCR)

Epidemiology

ʻO ka maʻi influenza, ka mea maʻamau i kapa ʻia ʻo 'flu', he maʻi maʻi ʻeha hanu i hoʻokumu ʻia e ka maʻi maʻi influenza, he maʻi maʻi nui loa a hoʻouna ʻia e ka ʻuʻu a me ke kihe.

ʻO ka maʻi maʻi hanu hanu (RSV) he maʻi RNA, no ka ʻohana paramyxoviridae.

ʻO ke kanaka adenovirus (HAdV) he maʻi DNA stranded ʻelua me ka ʻole o ka envelopp. Ma kahi o 90 mau genotypes i loaʻa, hiki ke māhele ʻia i 7 subgenera AG.

He lālā ʻo Human Rhinovirus (HRV) o ka ʻohana Picornaviridae a me ka genus Enterovirus.

ʻO ka Mycoplasma pneumoniae (MP) he microorganism pathogenic i waena o nā hua bacteria a me nā maʻi maʻi i ka nui.

Kanal

Kanal	PCR-Mix A	PCR-Mix B
Kanal FAM	IFV A	HAdV
Kaila VIC/HEX	HRV	IFV B
CY5 Channel	RSV	MP
Kanal ROX	Hoomalu Kuloko	Hoomalu Kuloko

Nā ʻāpana ʻenehana

Waihona	-18 ℃
Kau-ola	12 mahina
ʻAno Hoʻohālike	ʻOropharyngeal swab
Ct	≤35
LoD	500 kope/mL
kikoo	1.Ua hōʻike ʻia nā hopena hoʻāʻo cross-reactivity ʻaʻohe hopena kea ma waena o ka kit a me ka coronavirus kanaka SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, Parainfluenza virus type 1, 2, a me 3, Chlamydia pneumoniae, metaponeumovirus kanaka, Enteroneuvirus, kanaka metaponeumovirus. ʻO ka maʻi Epstein-Barr, Measles virus, cytomegalovirus kanaka, Rotavirus, Norovirus, Mumps virus, Varicella-zoster virus, Legionella, Bordetella pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycoballius tuberculosis. albicans, Candida glabrata, Pneumocystis jiroveci, Cryptococcus neoformans a me nā waikawa nucleic genomic kanaka. 2.Hiki ke hoʻopilikia: Mucin (60mg / mL), 10% (v / v) koko kanaka, phenylephrine (2mg / mL), oxymetazoline (2mg / mL), sodium chloride (me nā preservatives) (20mg / mL), beclomethasone (20mg / mL), dexamethasone (20mg / mL), dexamethasone (20mg / mL), flunisolide (20mg / mL). acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), Fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), alpha-interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oselngtamivir (10mg/mL) lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), cefprozil (40μg/mL), Meropenem (200mg/mL), levofloxacin (10μg/mL), a me tobramycin (0. ʻAʻohe mea hoʻopilikia i nā hopena hoʻāʻo o nā pathogens.
Nā mea hana pili	Hoʻohana ʻia Biosystems 7500 Pūnaehana PCR manawa maoli Hoʻohana ʻia ʻo Biosystems 7500 Fast Real-Time PCR Systems QuantStudio^®5 Pūnaehana PCR manawa maoli SLAN-96P Pūnaehana PCR Manawa maoli LightCycler^®480 Pūnaehana PCR manawa maoli LineGene 9600 Plus Pūnaehana ʻIke PCR manawa maoli MA-6000 ʻOiaʻiʻo ka nui o ka wela wela ʻO BioRad CFX96 Pūnaehana PCR manawa maoli, BioRad CFX Opus 96 Pūnaehana PCR manawa maoli.

Huina PCR

ʻEono ʻano o ka Respiratory Pathogen Nucleic Acid Detection Kit (Fluorescence PCR)

Nā kiʻi kikoʻī huahana:

Alakaʻi Huahana Pili:

ʻO ka sincerity, Innovation, Rigorousness, and Efficiency ka manaʻo hoʻomau o kā mākou ʻoihana no ka wā lōʻihi e hoʻomohala pū me nā mea kūʻai aku no ka launa like ʻana a me ka pōmaikaʻi like ʻole no ka Respiratory Pathogens Combined, E hāʻawi ka huahana i nā wahi āpau o ka honua, e like me: Belgium, British, Netherlands, ʻO kā mākou huahana āpau i lawe ʻia aku i nā mea kūʻai aku ma UK, ʻAmelika, ʻAmelika, ʻAmelika, ʻApelika, ʻApelika a me Kanada. Hoʻokipa maikaʻiʻia kā mākou huahana e kā mākou mau mea kūʻai no ke kūlana kiʻekiʻe, nā kumukūʻai hoʻokūkū a me nāʻano maikaʻi loa. Manaʻo mākou e hoʻokumu i ka pilina ʻoihana me nā mea kūʻai aku a lawe mai i nā kala nani no ke ola.

kūʻai aku i ka pahu ʻike hoʻomaʻi hanu